Discontinued — last reported Q4 '23
Baby Feminineand Family Care — Restructuring Charges
Procter & Gamble Baby Feminineand Family Care — Restructuring Charges remained flat by 0.0% to $5.25M in Q2 2023 compared to the prior quarter. Year-over-year, this metric declined by 74.7%, from $20.75M to $5.25M. Over 2 years (FY 2021 to FY 2023), Baby Feminineand Family Care — Restructuring Charges shows a downward trend with a -14.9% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
High charges indicate active restructuring efforts, which may temporarily depress earnings but are intended to improve future profitability.
Detailed definition
This metric captures the costs associated with organizational changes, such as facility closures, workforce reductions,...
Peer comparison
Comparable to restructuring or impairment charges reported by other large-scale consumer goods companies undergoing operational transformation.
pg_segment_baby_feminine_family_care_restructuring_chargesHistorical Data
| FY'21 | FY'22 | FY'23 | |
|---|---|---|---|
| Value | $29M | $83M | $21M |
| YoY Change | — | +186.2% | -74.7% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Procter & Gamble's baby feminineand family care — restructuring charges?
- Procter & Gamble (PG) reported baby feminineand family care — restructuring charges of $5.25M in Q2 2023.
- How has Procter & Gamble's baby feminineand family care — restructuring charges changed year-over-year?
- Procter & Gamble's baby feminineand family care — restructuring charges decreased by 74.7% year-over-year, from $20.75M to $5.25M.
- What is the long-term trend for Procter & Gamble's baby feminineand family care — restructuring charges?
- Over 2 years (2021 to 2023), Procter & Gamble's baby feminineand family care — restructuring charges has grown at a -14.9% compound annual growth rate (CAGR), from $29M to $21M.
- What does baby feminineand family care — restructuring charges mean?
- The costs incurred to reorganize or streamline the operations of the Baby, Feminine & Family Care segment.